SurpassMD Tirzepatide Review: Intro Offers, Renewal & Supply Terms

SurpassMD's current tirzepatide page provides more detail than its $177 introductory headline suggests. That lowest figure is attached to a twelve-month supply term. The 30-day option is listed at $247 introductory and $309 standard renewal, with different equivalents for longer terms.¹

Our view: the published table is useful, but compare the full term and renewal together. The lowest monthly equivalent should not be read as a flexible monthly price, and the cancellation deadline remains material even when a plan advertises no separate membership fee.

What the price actually covers

The current table lists introductory and standard renewal monthly equivalents as follows: 30 days $247/$309, three months $232/$299, six months $220/$275 and twelve months $177/$222. The page says provider review, medication, shipping and support are included and prescribed dose increases do not raise the program price.¹

Ask whether the longer-term totals are paid upfront and whether renewals repeat the same term. The twelve-month introductory arithmetic is $2,124; the standard equivalent would be $2,664 over twelve months if those rates apply across the full respective terms. Those calculations describe the table, not a confirmed invoice or shipment schedule.

Do not use the site's generic brand comparison as your personal Zepbound cost. Branded options differ by presentation, dose and eligibility, so compare a separate current medication quote.

Care, prescription and pharmacy access

The program describes clinician review, ongoing support and shipment from the dispensing pharmacy, with marketing for fifty states plus DC. The assigned pharmacy was not named in the reviewed pages, and individual access still depends on clinical and dispensing eligibility.¹

Ask how regular follow-ups are arranged and whether a live appointment is included when needed. Also ask how a longer supply term works if the clinician adjusts the prescription. Paying for a year of program access should not be mistaken for receiving one fixed medication plan that cannot change.

Cancellation and practical limits

The current refund policy requires cancellation at least 72 hours before billing; a late request allows another charge before cancellation takes effect. It promises a full refund for initial medical disqualification and separately discusses refunds of remaining service after clinician disqualification. Ordinary cancellation does not receive a routine refund.²

These provisions deserve an explicit answer for prepaid terms. Ask how the remainder is calculated if clinical disqualification happens during a longer plan, and retain the response. Confirm the amount owed if you simply choose to leave for a different provider rather than being medically disqualified.

Follow the footnote through to renewal

The pricing footnote says the introductory rate requires a SurpassMD discount code and applies to the first subscription; the standard amount is the renewal rate. It also identifies the generic brand comparison as wholesale acquisition cost for one four-pen fill, not an individualized pharmacy price.¹ That makes the introductory conditions and the brand-price comparison less mysterious, but does not settle the collection schedule for a longer term.

The three-month table works out to $696 introductory versus $897 at the displayed standard monthly equivalent, a $201 difference over that term. The six-month equivalents produce $1,320 versus $1,650, a $330 difference. Ask which amount is charged and whether the code applies to the entire initial subscription or a narrower period before treating those products as invoices.

SurpassMD also identifies the program as direct pay rather than insurance billing.¹ This may simplify one part of the transaction, but it matters if you expect an insurer to fund treatment. Compare an actual covered branded option separately rather than assuming the site's wholesale brand comparator reflects your alternative.

How it compares

Compare Refills for another term-based compounded schedule and CaliberRx for a program whose policy separates care and pharmacy charges. Use the standard renewal amount and full commitment when judging affordability.

Our Zepbound cost guide gives context beyond the generic branded comparison on the page. Read the compounded-tirzepatide guide and dosing overview before equating a longer supply term with a fixed treatment plan.

Clinical review does not make a compounded preparation FDA-approved. Discuss why an approved medication would or would not meet your needs.³

Our assessment

SurpassMD’s current table makes the introductory-versus-renewal difference visible. Use the rate for your actual term, not the $177 headline in isolation, and clarify what happens to a prepaid balance if clinical eligibility changes.